Elucidating the mechanism of glucagon-like peptide-1 for glucose utilization during periods of fasting

被引：0
|
作者：
Schurr, Kathleen [1 ]
Edgerton, Dale S. [2 ]
Farmer, Tiffany [2 ]
Neal, Doss [2 ]
Cherrington, Alan D. [2 ]
Johnson, Kathryn M. S. [1 ,2 ]
机构：
[1] Beloit Coll, Dept Biol, Beloit, WI 53511 USA
[2] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
来源：
FASEB JOURNAL | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Glucagon and glucagon-like peptide-1
    Livingston, JN
    Schoen, WR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 189 - 198
  • [2] Glucagon-like peptide-1, glucose homeostasis and diabetes
    Holst, Jens J.
    Deacon, Carolyn F.
    Vilsboll, Tina
    Krarup, Thure
    Madsbad, Sten
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) : 161 - 168
  • [3] Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
    Cho, Young Min
    Fujita, Yukihiro
    Kieffer, Timothy J.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 : 535 - 559
  • [4] Cellular glucose availability and glucagon-like peptide-1
    Park, Jae-Hyung
    Earm, Yung E.
    Song, Dae-Kyu
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2011, 107 (02): : 286 - 292
  • [5] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399
  • [6] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [7] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [8] Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor
    Burmeister, M. A.
    Bracy, D. P.
    James, F. D.
    Holt, R. M.
    Ayala, J.
    King, E. M.
    Wasserman, D. H.
    Drucker, D. J.
    Ayala, J. E.
    JOURNAL OF PHYSIOLOGY-LONDON, 2012, 590 (20): : 5245 - 5255
  • [9] GLUCAGON-LIKE PEPTIDE-1 HAS NO GLUCAGON-LIKE EFFECT ON PLASMA-GLUCOSE AND INSULIN
    GHIGLIONE, M
    UTTENTHAL, LO
    GEORGE, SK
    BLOOM, SR
    DIABETOLOGIA, 1984, 27 (02) : A278 - A279
  • [10] UTILIZATION OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN CANADA
    Vannabouathong, C.
    Le, K.
    Dyrda, P.
    VALUE IN HEALTH, 2023, 26 (06) : S217 - S217
12345